Helport AI Opens Thailand Office 
playX Receives the ‘Enterprise Award’ at the Asia Golden Star Awards in Tokyo 
Zhibao Technology Announces Receipt of Nasdaq Deficiency Letter 
Fairfax County and Penzance Officials Break Ground on Next-Generation Digital Infrastructure Project to Power the World’s Deep Tech Future Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2021
Monthly information regarding the total number of voting rights and total number of shares of…
Medexus to Present at Canaccord Genuity’s 41st Annual Growth Conference
TORONTO and CHICAGO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”)…
Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
EXTON, Pa., Aug. 09, 2021 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or the “Company”)…
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
– Recommended Phase 2 Dose of IGM-2323 Expected in 2021 – – Initial Data from…
Paratek Pharmaceuticals Announces Total Revenue of $57.5 Million in the Second Quarter 2021
— NUZYRA® (omadacycline) Generated Net U.S. Sales of $14.9 Million from the Core Commercial Business, a…
Vor Reports Second Quarter 2021 Financial Results and Provides Company Update
On track to report initial VOR33 clinical data in the first half of 2022 Announced…
AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline Updates
Imsidolimab GPP GEMINI-1 Phase 3 trial anticipated to initiate in Q3 2021 following recent FDA end-of-Phase…
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
Preclinical Data Support Initiation of Clinical Development of Lead GeneTAC Program for Friedreich Ataxia in…
NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates
Announcing first solid tumor indication in HPV associated-malignancies – NEXI-003 Advancing two lead product candidates…
Recro Reports Second Quarter 2021 Financial Results
Q2 2021 Highlighted by Revenues of $18.0 Million, an Increase of 16% Compared to Q2…
Tricida Announces Second Quarter 2021 Financial Results
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE…
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
– SAD cohorts up to 640 mg and MAD cohorts up to 320 mg completed…
VistaGen Therapeutics to Report Fiscal Year 2022 First Quarter Financial Results and Host Conference Call and Webcast on August 12, 2021
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN),…
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Turning Point Therapeutics Reports Second-Quarter Financial Results, Provides Operational Updates
Phase 1/2 TRIDENT-1 Enrollment Reaches Approximately 300 Patients, Including More than 50 in the ROS1-Positive…
BioCryst Commences Public Offering of Common Stock and Pre-Funded Warrants
RESEARCH TRIANGLE PARK, N.C., Aug. 09, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Cara Therapeutics Reports Second Quarter 2021 Financial Results
– New Drug Application (NDA) Filing for KORSUVA™ Injection in CKD-aP under Priority Review by…
Apellis Pharmaceuticals Reports Second Quarter 2021 Financial Results
Received approval for EMPAVELI™ (pegcetacoplan) – the first targeted C3 therapy – from U.S. Food and…
Impel NeuroPharma to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
SEATTLE, Aug. 09, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a late-stage biopharmaceutical…
FibroGen Reports Second Quarter 2021 Financial Results
• Roxadustat net product revenue in China of $13.4 million, on a US GAAP basis. •…